| Título : |
Overactive bladder - 18 years - Part I |
| Tipo de documento : |
documento electrónico |
| Autores : |
Juan Carlos Castaño Botero, |
| Fecha de publicación : |
2016 |
| Títulos uniformes : |
International Brazilian Journal of Urology
|
| Idioma : |
Inglés (eng) |
| Palabras clave : |
Overactive Bladder Muscarinic Antagonists Beta-adrenergic agonists Botulinum Toxin Sacral neuromodulation Urodynamics |
| Resumen : |
Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals – including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years. |
| Mención de responsabilidad : |
Jose Carlos Truzzi, Cristiano Mendes Gomes, Carlos A Bezerra, Ivan Mauricio Plata, Jose Campos, Gustavo Luis Garrido, Fernando G Almeida, Marcio Augusto Averbeck, Alexandre Fornari, Anibal Salazar, Arturo Dell'Oro, Caio Cintra, Carlos Alberto Ricetto Sacomani, Juan Pablo Tapia, Eduardo Brambila, Emilio Miguel Longo, Flavio Trigo Rocha, Francisco Coutinho, Gabriel Favre, Jose Antonio Garcia, Juan Castano, Miguel Reyes, Rodrigo Eugenio Leyton, Ruiter Silva Ferreira, Sergio Duran, Vanda Lopez, Ricardo Reges |
| Referencia : |
Int Braz J Urol. 2016 Mar-Apr;42(2):188-98. |
| DOI (Digital Object Identifier) : |
10.1590/S1677-5538.IBJU.2015.0365 |
| PMID : |
27176184 |
| Derechos de uso : |
CC BY |
| En línea : |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000200188&l [...] |
| Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3981 |
Overactive bladder - 18 years - Part I [documento electrónico] / Juan Carlos Castaño Botero, . - 2016. Obra : International Brazilian Journal of UrologyIdioma : Inglés ( eng) | Palabras clave : |
Overactive Bladder Muscarinic Antagonists Beta-adrenergic agonists Botulinum Toxin Sacral neuromodulation Urodynamics |
| Resumen : |
Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals – including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years. |
| Mención de responsabilidad : |
Jose Carlos Truzzi, Cristiano Mendes Gomes, Carlos A Bezerra, Ivan Mauricio Plata, Jose Campos, Gustavo Luis Garrido, Fernando G Almeida, Marcio Augusto Averbeck, Alexandre Fornari, Anibal Salazar, Arturo Dell'Oro, Caio Cintra, Carlos Alberto Ricetto Sacomani, Juan Pablo Tapia, Eduardo Brambila, Emilio Miguel Longo, Flavio Trigo Rocha, Francisco Coutinho, Gabriel Favre, Jose Antonio Garcia, Juan Castano, Miguel Reyes, Rodrigo Eugenio Leyton, Ruiter Silva Ferreira, Sergio Duran, Vanda Lopez, Ricardo Reges |
| Referencia : |
Int Braz J Urol. 2016 Mar-Apr;42(2):188-98. |
| DOI (Digital Object Identifier) : |
10.1590/S1677-5538.IBJU.2015.0365 |
| PMID : |
27176184 |
| Derechos de uso : |
CC BY |
| En línea : |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000200188&l [...] |
| Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3981 |
|  |
Inicio
Overactive bladder - 18 years - Part I
